Santa Cruz Biotechnology is a world leader in the development of products for the biomedical research market. Over the past 30+ years, the Company has focused on the ongoing development of research ...
Hosted on MSN
Biotech Ingredients Are Beauty’s Next Big Thing—Here’s How They’re Changing Skincare as We Know It
When it comes to beauty formulations that are inclusive of people and planet, finding a middle ground is not always easy. Natural ingredients often rely on farming practices that often require a lot ...
Our Food & Beverage and FDA teams explore a plan from a trio of federal agencies that seeks to implement regulatory reform and update the Coordinated Framework for the Regulation of Biotechnology. The ...
Saudi Gazette on MSN
SFDA: 83% growth in clinical research for biotechnology products in 2025
Saudi Gazette reportRIYADH — Saudi Arabia recorded a significant 83 percent growth in the number of clinical trial applications submitted to the Saudi Food and Drug Authority (SFDA) for advanced ...
In trading on Monday, biotechnology shares were relative laggards, down on the day by about 3%. Helping drag down the group were shares of Quince Therapeutics, down about 16.2% and shares of Kalaris ...
Between 1973 and 2016, the ways to manipulate DNA to endow new characteristics in an organism (that is, biotechnology) have advanced, enabling the development of products that were not previously ...
The global biotechnology market was valued at USD 1.55 trillion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 13.96% from 2024 to 2030, reaching USD 3.88 trillion by 2030 ...
The SFDA reported that approximately 2,700 patients have benefited from access to innovative and advanced treatments through ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results